Syndrome: Pneumonia, community acquired - inpatient, ICU, pseudomonas
Primary Therapy(s):
- (Cefepime 2gm IV q8 or Pip/tazo 4.5 gm IV q 6 or Imipenem/Meropenem) + (Cipro 400 mg IV q12 or levofloxacin 750 mg qd)
Alternate Therapy(s):
- (Pip/tazo or Cefepime or Imipenem/ Meropenem) + Tobramycin + Azithromycin
- Aztreonam + (Levofloxacin or Moxifloxacin)
Comments: Add vancomycin (or linezolid) for MRSA risk
Guideline Index Guideline Table
2nd generation cephalosporins--Cefuroxime, Cefpodoxime
Respiratory quionlones--Levofloxacin, Moxifloxacin
Respiratory quionlones--Levofloxacin, Moxifloxacin